Drug Research
Gritgen Therapeutics Launches Commercial GMP Facility in China
Gritgen Therapeutics Co., a biotechnology company focused on gene therapy products, reported the successful validation and launch of operations at its commercial GMP facility in...
Drug Research
Cellipont and Diakonos to develop cell therapy for glioblastoma
Cellipont Bioservices has signed an agreement with Diakonos Oncology for the development of DOC1021, a cell therapy to treat glioblastoma multiforme (GBM).
The parties will carry...
BioPharma
Cryoport, CGT Catapult Partner on Cell and Gene Therapies
Cryoport, Inc. , a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine...
News
Cold Chain Technologies Acquires Exeltainer, Expanding its Presence in Europe and Latin America
Cold Chain Technologies, LLC, a leading provider of thermal packaging solutions for the transportation of temperature-sensitive products for the life sciences industry, announced it has...
News
Phastar Net-Zero Target Approved by the Science Based Targets Initiative
Phastar, a global specialist biometrics contract research organization (CRO), has had its net-zero target approved by the Science Based Targets initiative (SBTi). The SBTi is...
News
Drugmakers Enrol For First US Medicare Price Negotiations
All drug manufacturers responsible for manufacturing the 10 prescription medicines that will be subject to the inaugural price negotiations for the U.S. Medicare health programme,...
News
3 Tech Innovations That Changed The Game For Mental Health
Hear us out, everyone: technology addiction is real. It’s true that technology improves communication and enhances efficiency and productivity, but its overuse could be dangerous.
Increasing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.